92 related articles for article (PubMed ID: 229752)
1. Plasma and urine cyclic guanosine 3':5'-monophosphate in disseminated cancer.
Chawla RK; Nixon DW; Shoji M; Rudman D
Ann Intern Med; 1979 Dec; 91(6):862-4. PubMed ID: 229752
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma and urinary guanosine 3':5'-monophosphate and increased production rate in patients with neoplastic diseases.
Chawla RK; Shlaer SM; Lawson DH; Murray TG; Schmidt F; Shoji M; Nixon DW; Richmond A; Rudman D
Cancer Res; 1980 Nov; 40(11):3915-20. PubMed ID: 6258769
[TBL] [Abstract][Full Text] [Related]
3. Plasma and urine cyclic nucleotide levels in patients with neoplastic diseases.
Peracchi M; Lombardi L; Toschi V; Bamonti-Catena F; Mandelli V; Maiolo AT; Baldini L; Polli EE
Cancer; 1984 Dec; 54(12):3028-34. PubMed ID: 6093991
[TBL] [Abstract][Full Text] [Related]
4. Plasma and urine cyclic nucleotide levels in patients with acute and chronic leukemia.
Peracchi M; Lombardi L; Maiolo AT; Bamonti-Catena F; Toschi V; Chiorboli O; Mozzana R; Polli EE
Blood; 1983 Mar; 61(3):429-34. PubMed ID: 6297636
[TBL] [Abstract][Full Text] [Related]
5. Adenosine 3',5'-cyclic monophosphate and guanosine 3',5'-cyclic monophosphate levels in human breast cancer tissue.
Guerinot F; Delarue JC; Contesso G; Bohuon C
Oncology; 1977; 34(6):261-3. PubMed ID: 201896
[TBL] [Abstract][Full Text] [Related]
6. Plasma and urine cyclic nucleotide levels in patients with hyperthyroidism and hypothyroidism.
Peracchi M; Bamonti-Catena F; Lombardi L; Reschini E; Toschi V; Maiolo AT; Polli EE
J Endocrinol Invest; 1983 Jun; 6(3):173-7. PubMed ID: 6311890
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the levels of cyclic cytidine 3':5'-monophosphate, cyclic guanosine 3':5'-monophosphate, and cyclic adenosine 3':5'-monophosphate in urines and leukocytes and the type of human leukemias.
Scavennec J; Carcassonne Y; Gastaut JA; Blanc A; Cailla HL
Cancer Res; 1981 Aug; 41(8):3222-7. PubMed ID: 6265079
[TBL] [Abstract][Full Text] [Related]
8. Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment.
Turner GA; Ellis RD; Guthrie D; Latner AL; Monaghan JM; Ross WM; Skillen AW; Wilson RG
J Clin Pathol; 1982 Aug; 35(8):800-6. PubMed ID: 6286732
[TBL] [Abstract][Full Text] [Related]
9. Plasma and urine cyclic nucleotide levels in malignant disease and cirrhosis of the liver.
Wood PJ; Ross G; Smith CL
J Clin Pathol; 1979 Oct; 32(10):998-1002. PubMed ID: 230205
[TBL] [Abstract][Full Text] [Related]
10. [Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) levels in cancer tissue, plasma and urine of esophageal cancer patients].
Zhao CY
Zhonghua Zhong Liu Za Zhi; 1985 May; 7(3):175-7. PubMed ID: 2990838
[No Abstract] [Full Text] [Related]
11. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
Blonde L; Wehmann RE; Steiner AL
J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in normal children and those with cystic fibrosis.
Murad F; Moss WW; Johanson J; Selden RF
J Clin Endocrinol Metab; 1975 Apr; 40(4):552-9. PubMed ID: 165210
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate in malignancy.
Gennari C; Francini G; Galli M; Lore F
J Clin Pathol; 1978 Aug; 31(8):735-41. PubMed ID: 211147
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of cyclic 3',5'-adenosine monophosphate and cyclic 3',5'-guanosine monophosphate during and after pregnancy.
Kopp L; Paradiz G; Tucci JR
J Clin Endocrinol Metab; 1977 Mar; 44(3):590-4. PubMed ID: 190264
[TBL] [Abstract][Full Text] [Related]
15. Cyclic nucleotide excretion in human malignancies.
Hunt NH; Smith B; Pembrey R
Clin Sci (Lond); 1980 Jun; 58(6):463-7. PubMed ID: 6253117
[TBL] [Abstract][Full Text] [Related]
16. Increased plasma cyclic nucleotide concentrations in congestive heart failure.
Ogawa K; Shiozu H; Mizuno K; Ban M; Ito T; Satake T
Br Heart J; 1984 Nov; 52(5):524-9. PubMed ID: 6093837
[TBL] [Abstract][Full Text] [Related]
17. Urinary excretion of cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate in rats bearing transplantable liver and kidney tumors.
Criss WE; Murad F
Cancer Res; 1976 May; 36(5):1714-6. PubMed ID: 178429
[TBL] [Abstract][Full Text] [Related]
18. Effect of angiotensin II on cyclic guanosine monophosphate and cyclic adenosine monophosphate in human plasma.
Rosman PM; Agrawal R; Goodman AD; Steiner AL
J Clin Endocrinol Metab; 1976 Mar; 42(3):531-6. PubMed ID: 176170
[TBL] [Abstract][Full Text] [Related]
19. Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepatocellular carcinoma.
Bamonti-Catena F; Peracchi M; Conte D; Cantalamessa L; Lorenzano E; Orsatti A; Salerno F
Clin Chem Lab Med; 1998 Sep; 36(9):709-14. PubMed ID: 9804395
[TBL] [Abstract][Full Text] [Related]
20. Circadian rhythms in the urinary excretion of cyclic 3',5'-adenosine monophosphate (cyclic AMP) and cyclic 3',5'-guanosine monophosphate (cyclic GMP) in human subjects.
Kopp L; Lin T; Tucci JR
J Clin Endocrinol Metab; 1977 Apr; 44(4):673-80. PubMed ID: 191467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
